🟢 Trulieve Cannabis is trading 5.56% up in pre-market ahead of its Q2 earnings release

Trulieve Cannabis is trading 5.56% up at $9.50 ahead of its August 7, 2026, second-quarter earnings release.

• Results are scheduled before market open, followed by an 8:30 a.m. Eastern conference call.
• Investors are focused on potential Schedule III benefits, including lower cash taxes from Section 280E relief.
• The broader market is mixed before payrolls; confidence is medium, with no reported results available at 4:31 a.m. Eastern.